Harrow (HROW) Current Leases (2014 - 2026)
Harrow's (HROW) quarterly Current Leases came in at $915000.0 in Q1 2026, up 49.75% year-on-year from $611000.0 in Q1 2025, and up 3.16% quarter-over-quarter from $887000.0 in Q4 2025.
Harrow (HROW) Current Leases (2014 - 2026) Analysis & Trends
Harrow's Current Leases history runs 13 years deep, the most recent figure standing at $915000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 49.75% year-over-year to $915000.0 in Q1 2026; TTM through Mar 2026 was $915000.0, a 49.75% increase from a year earlier, with the FY2025 full-year figure at $887000.0, up 78.47% from the prior year.
- Current Leases climbed to $915000.0 in Q1 2026 per HROW's latest filing, from $887000.0 in the prior quarter.
- Across five years, Current Leases topped out at $915000.0 in Q1 2026 and bottomed at $445000.0 in Q1 2022.
- The 5-year median for Current Leases is $764000.0 (2023), against an average of $719000.0.
- Across the five-year window, Current Leases soared 8937.5% in 2022 and sank 38.34% in 2024, its largest moves.
- Year by year, Current Leases stood at $723000.0 in 2022, then rose by 11.48% to $806000.0 in 2023, then sank by 38.34% to $497000.0 in 2024, then soared by 78.47% to $887000.0 in 2025, then advanced by 3.16% to $915000.0 in 2026.
- Per Business Quant, the three latest HROW Current Leases figures stand at $915000.0 (Q1 2026), $887000.0 (Q4 2025), and $859000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | 915,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 915,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 859,000.00 |
| Jun 30, 2025 | 782,000.00 |
| Mar 31, 2025 | 611,000.00 |
| Dec 31, 2024 | 497,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 767,000.00 |
| Mar 31, 2024 | 795,000.00 |
| Dec 31, 2023 | 806,000.00 |
| Sep 30, 2023 | 785,000.00 |
| Jun 30, 2023 | 764,000.00 |
| Mar 31, 2023 | 744,000.00 |
| Dec 31, 2022 | 723,000.00 |
| Sep 30, 2022 | 703,000.00 |
| Jun 30, 2022 | 633,000.00 |
| Mar 31, 2022 | 445,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 388,000.00 |
| Jun 30, 2021 | 485,000.00 |